223 (Lithium carbonate extended release 300 mg)

Pill imprint 223 has been identified as Lithium carbonate extended release 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; intermittent explosive disorder; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 223

Lithium carbonate extended release 300 mg 223
Lithium carbonate extended release 300 mg 223
Lithium carbonate extended release 300 mg 223
Lithium carbonate extended release
Imprint:
223
Strength:
300 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0223
Inactive Ingredients:
sodium chloride
povidone k30
sorbitol
sodium starch glycolate type A potato
calcium stearate
sodium lauryl sulfate
hypromellose 2910 (15000 mPa.s)
titanium dioxide
polyethylene glycol 400
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)